We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CENT icon
76
Central Garden & Pet Co
CENT
$2.71B
$1.96M 0.03%
+53,827
New +$2.08M
AFCG
77
AFC Gamma
AFCG
$60.9M
$1.95M 0.03%
+191,162
New +$1.85M
PHGE icon
78
BiomX
PHGE
$2.13M
$1.82M 0.03%
94,085
+61,927
+193% +$2.25M
OTTR icon
79
Otter Tail
OTTR
$3.87B
$1.75M 0.03%
22,452
+9,845
+78% +$852K
WSO icon
80
Watsco Inc
WSO
$15B
$1.67M 0.03%
+3,401
New +$1.63M
DFIN icon
81
Donnelley Financial Solutions
DFIN
$1.26B
$1.64M 0.02%
+24,968
New +$1.62M
UAA icon
82
Under Armour
UAA
$3.02B
$1.64M 0.02%
+184,457
New +$1.37M
LOW icon
83
Lowe's Companies
LOW
$119B
$1.6M 0.02%
5,913
-2,200
-27% -$533K
FBNC icon
84
First Bancorp
FBNC
$2.59B
$1.6M 0.02%
+38,451
New +$1.53M
OXM icon
85
Oxford Industries
OXM
$602M
$1.58M 0.02%
18,184
+8,253
+83% +$760K
PINC
86
DELISTED
Premier
PINC
$1.58M 0.02%
+78,878
New +$1.57M
IEX icon
87
IDEX
IEX
$16.6B
$1.52M 0.02%
+7,106
New +$1.43M
BDX icon
88
Becton Dickinson
BDX
$43.8B
$1.52M 0.02%
6,312
+1,315
+26% +$308K
PRVA icon
89
Privia Health
PRVA
$3.11B
$1.46M 0.02%
+79,941
New +$1.53M
BYRN icon
90
Byrna Technologies
BYRN
$93.7M
$1.44M 0.02%
+85,037
New +$1.01M
ANDE icon
91
Andersons Inc
ANDE
$2.54B
$1.44M 0.02%
28,632
+7,671
+37% +$380K
MMS icon
92
Maximus
MMS
$3.2B
$1.43M 0.02%
15,377
+1,814
+13% +$162K
ODFL icon
93
Old Dominion Freight Line
ODFL
$47.2B
$1.43M 0.02%
+7,199
New +$1.4M
JOE icon
94
St. Joe Company
JOE
$3.56B
$1.42M 0.02%
+24,428
New +$1.43M
WEAV icon
95
Weave Communications
WEAV
$529M
$1.39M 0.02%
+108,555
New +$1.14M
EXAS
96
DELISTED
Exact Sciences
EXAS
$1.39M 0.02%
+20,341
New +$1.15M
IDXX icon
97
Idexx Laboratories
IDXX
$43.9B
$1.34M 0.02%
2,643
+729
+38% +$354K
USNA icon
98
Usana Health Sciences
USNA
$412M
$1.29M 0.02%
34,136
+4,394
+15% +$181K
LFMD icon
99
LifeMD
LFMD
$187M
$1.26M 0.02%
241,329
+201,040
+499% +$1.16M
STRO icon
100
Sutro Biopharma
STRO
$398M
$1.25M 0.02%
+35,992
New +$1.41M
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.